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Abstract
Background: Tuberculosis is a serious public health problem worldwide. It is the leading cause of death amongst
people living with HIV, and default from tuberculosis (TB) treatment in people living with HIV increases the probability
of death. The aim of this study was to estimate the survival probability of people living with HIV who default treatment
for TB compared to those who complete the treatment.
Methods: This was a longitudinal cohort study of people living with HIV, from June 2007 to December 2013 with two
components: a retrospective (for those who started tuberculosis treatment before 2013 for whom failure (death) or
censoring occurred before 2013), and prospective (those who started tuberculosis treatment at any time between 2007
and June 2013 and for whom death or censoring occurred after the beginning of 2013), at two referral hospitals for people
living with HIV (Correia Picanço Hospital - HCP and at Hospital Universitário Oswaldo Cruz – HUOC), in Recife/PE. A total of
317 patients who initiated TB treatment were studied. Default from TB treatment was defined as any patient who failed to
attend their pre-booked return appointment at the health center for more than 30 consecutive days, in accordance with
Brazilian Ministry of Health recommendations.
Results: From a cohort of 2372 people living with HIV we analyzed 317 patients who had initiated TB treatment. The
incidence of death was 5.6 deaths per 100 persons per year (CI 95% 4.5 to 7.08). Independent factors associated with
death: default from TB treatment 3.65 HR (95% CI 2.28 to 5.83); CD4 < 200 cells/mm3 2.39 HR (95% CI 1.44 to 3.96);
extrapulmonary tuberculosis 1.56 HR (95% CI 0.93 to 2.63); smoking 2.28 HR (95% CI 1.33 to 3.89); alcohol light 0.13
HR (95% CI 0.03 to 0.56).
Conclusion: The probability of death in people living with HIV who default TB treatment is approximately four times
greater when compared to those who do not default from treatment.
Keywords: Survival, Tuberculosis, Treatment, Default, Death
Background
Tuberculosis (TB) is a serious public health problem
worldwide [1–3], and is the leading cause of morbidity
and mortality in people living with HIV [4–7], who are
21 to 34 times more likely to develop TB when compared
to those without HIV [2]. The pulmonary and extrapul-
monary forms of tuberculosis are the most common op-
portunistic infections in people living with HIV [8, 9]. The
interaction between Mycobacterium tuberculosis and HIV
can cause elevation of viral load and decrease of CD4 + T
lymphocytes count, leading to accelerated decline in the
immune function and decreased survival [10] People liv-
ing with HIV have been considered as being more likely
to have unfavorable treatment outcomes of TB treatment,
due to the complexity of the management of co-infection
and to behavioral factors of this population [11]. Although
almost all patients who receive TB treatment are cured,
those living with HIV and undergoing concomitant treat-
ment for HIV infection and TB present a number of chal-
lenges, amongst which are: the long duration of therapy,
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the dosing frequency, the potential complex drug inter-
action and toxicity of the two therapies [1, 12–14]. There-
fore, numerous factors may influence the risk of
defaulting TB treatment and death in HIV-infected indi-
viduals. Some authors found an association between
defaulting from TB treatment and male sex, smoking,
lymphocyte CD4 count <200 cells per mm3, low salaries,
alcohol use, previous default from TB treatment, age
of 35–49 years old, illiteracy and previous treatment
for TB [15–18] Tuberculosis is the leading cause of
death in people living with HIV, causing a great im-
pact on the survival of this population. In turn, de-
fault from treatment features amongst the leading
causes of TB treatment failure in people living with
HIV, and may therefore be associated with a higher
mortality rate within this group [7, 15, 19]. This aim
of this study was to compare the survival probability
of people living with HIV who defaulted treatment
for TB with those who did not default treatment.
Methods
This study is nested in the AIDS Cohort of the state of
Pernambuco (Cohort AIDS-PE), a clinical cohort that
has collected information of more than 2300 patients
with HIV/AIDS attending two reference centers for the
care of HIV/AIDS patients in Recife, Brazil. The study
design was a longitudinal cohort with two components:
retrospective, (June 2007 to December 2012) and pro-
spective (January 2013 to December 2013). As we
started this investigation in the beginning of 2013,
people living with HIV who started tuberculosis treat-
ment before 2013 and for whom failure (death) or
censoring occurred before 2013, the study was retro-
spective. For those who started tuberculosis treatment at
any time between June 2007 and June 2013 and for
whom death or censoring occurred after the beginning
of 2013, the study was prospective. The same selection
procedures were used in the retrospective and prospect-
ive arm of the study. Patients attending two reference
centers for the treatment of HIV (Hospital Correia
Picanço and Hospital Universitário Oswaldo Cruz) were
enrolled in the study at the time they were notified to
the Surveillance System for Infectious Diseases (SINAN/
MS) as having tuberculosis. Registering the case in the
SINAN/MS is a prerequisite for initiation of TB treat-
ment. They were then invited to participate in the study
and after reading and signing the Informed Consent (IC)
forms, they were interviewed by previously trained staff
using a standardized questionnaire. Recruitment loss
ocurred when the patient was notified to the Surveillance
System for Infectious Diseases (SINAN/MS) as having tu-
berculosis but was not included in the study. Recruitment
loss occurred in the retrospective arm (n = 182) as well as
in the prospective (n = 10).
The study population consisted of people living with HIV
aged 18 and over who had initiated treatment for TB. In
our study TB cases were considered as those diagnosed of
TB by the attending physician (according to the Ministry of
Health of Brazil guidelines, that is based on clinical find-
ings, direct investigation of Acid-fast bacillus –AFB -smear
and culture for M.tb).and notified to the (SINAN/MS). De-
fault from TB treatment was defined as any patient who
failed to attend their pre-booked return appointment at the
health center for more than 30 consecutive days. The study
excluded individuals who presented any change in the
diagnosis of TB during follow-up, those with multidrug-
resistant TB (MDR-TB) and pregnant women. The re-
sponse variable of the study was the occurrence of all-cause
mortality. Information on the occurrence of death was
obtained from medical records and from the Mortality In-
formation System, ascertained through record linkage.
Death registration is compulsory in Brazil. There is no bur-
ial without a death certificate and the death certificate is
the source of information to the mortality system. The
Mortality Information System is a national and sub-
national electronic system with all routine mortality data
coded to International Coding Disease. Registration of
deaths is managed by the Ministry of Health in Brazil.
The main exposure was the default from treatment for
TB. Patients were classified as defaulters or non defaulters.
Defaulters were further classified according to the mo-
ment in which default ocurred (first quarter: meaning the
first three months after the start of tuberculosis treatment
and the second quarter meaning four to six months after
the start of tuberculosis treatment).
Co-variables were grouped into six categories: biological
variables (gender and age); variables related to habits and
lifestyle (smoking and drinking); socioeconomic factors
(income, place of residence and marital status); clinical
variables (body mass index [BMI] and anemia); HIV-
related variables (presence of opportunistic infection,
AIDS case, CD4 count and antiretroviral therapy [ART]);
variables related to tuberculosis (place of treatment, form
of TB and previous treatment). Amongst the lifestyle vari-
ables, smoking was considered as the habit of cigarette
smoking and categorized as: non-smokers (those who had
never smoked during their lifetime); former smokers
(those who had given up smoking at least six months prior
to enrolling on the study); smokers (those who were
smoking at the time of enrollment or had stopped smok-
ing during the previous six months). Alcohol consumption
was regarded as consuming alcoholic beverages and
categorized as: abstainer (has never drunk or drinks less than
8 units/year); light drinker (drinks twice a week, at max-
imum, not exceeding 10 units/month); moderate drinker
(drinks at least 3 or 4 times per week, exceeding 5 units/day);
heavy drinker (undergoing treatment for alcoholism). The
CD4+ count was considered as that observed at the time of
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initiating TB treatment and categorized as: greater than or
equal to 200 cells/mm3 and less than 200 cells/mm3. The
clinical form of TB was defined as the organ or tissue affected
by the disease and categorized as: pulmonary TB (disease
restricted to the lungs); extrapulmonary TB (when the disease
involved organs other than the lungs); disseminated TB
(involvement of two non-contiguous sites).
Statistical analysis
For the data analysis, we considered the alpha level = 5%
and a confidence interval (CI) of 95%. In the survival
analysis, the Kaplan-Meier method was used to compare
the probability of survival between those who defaulted
from tuberculosis treatment and those who did not and
the median survival time, and the log-rank test to test
the statistical significance of the difference between the
curves and compare survival curves. The death rate was
expressed in person/years; time was measured since the
start of tuberculosis treatment until death or failure. The
semi-parametric regression Cox model was adopted to
identify factors associated with survival time, in which
the hazard ratio [HR] was used as the measurement of
association. The association between default from tuber-
culosis treatment and death was adjusted for confound-
ing factors. Deaths were identified by pairing individuals
from the cohort during the follow-up period and the
Mortality Information System of Pernambuco (SIM-PE),
using the probabilistic linkage program RecLink III [20].
For the statistical analysis in the survival model we used
STATA 12.0. The data entry and double entry validation
were performed in parallel with data collection, and the
database was managed by the SQL Server 2000 (Micro-
soft), using GeneXus software (version 7.5).
Ethical considerations
The study was approved by the Research Ethics Commit-
tee at HUOC/PROCAPE/UPE on 02/07/2014, Report n°:
706. 132/CAAE: 30621114.8.0000.5192 and by the Ethics
Committee of the Universidade Federal de Pernambuco,
registered in the National System on Research Ethics
(SISNEP) FR-067 159/CAAE-0004.1.172.106-05/REGIS-
TRATION CEP/Health Sciences Center/Universidade
Federal de Pernambuco (UFPE) Report n° 254/05 and
funded by the Ministry of Health and Ministry of Science
and Technology - CNPq/MS-SCTIE-DECIT (Case 10567/
2006-0).
Results
Out of 512 people living with HIV who initiated tubercu-
losis treatment, 317 were included in the study. Losses
occurred because of: recruitment loss (n = 182, retrospective
arm= 170 and prospective arm= 12), change in diagnosis
(n = 5), not signing informed consent forms (n = 5) and loss
to followup (n = 3). Of the 317 patients studied, 91 (28.7%)
defaulted treatment for TB, while 226 (70.9%) did not
(Fig. 1). A total of 59 individuals underwent further treat-
ment for TB during follow-up, and contributed more than
once to the cohort, thus resulting in a total of 375 treatment
episodes for the entire cohort. From amongst these, there
were 111defaults from TB treatment (29.6%) (Table 1), 47
(42.7%) during the first three months after the start of TB
treatment and 63 (57.3%) between the fourth and sixth
month after the start of TB treatment; the date of default of
one patient was not recorded. From the 317 patients
studied, 75 (23.6%) deaths were recorded during the study
period. (Table 1) In the first year of follow-up there were 14
deaths (18.6%), in the second there were 25 (33.3%) and in
the third year 36 (48%). Amongst the cases of death, 36
(48%) occurred in the group that did not default TB treat-
ment, 20 (26.7%) in the group that defaulted treatment in
the first quarter and 19 (25.3%) in the group that defaulted
treatment in the second quarter. In the group that did not
default treatment, 38.9% of the deaths occurred within two
years of initiating treatment for TB, while the percentages
of death for those who defaulted treatment in the first and
second quarter were, respectively, 70% and 57.9%. (Table 2)
The death rate amongst patients who defaulted TB treat-
ment was 14.4 deaths per 100 person/years (95% CI: 10.5 to
19.7) and among patients who did not default treatment 3.4
deaths per 100 person/years (95% CI: 2.46 to 4.72) (Fig. 2).
The probability of death for patients who defaulted treat-
ment was 3.91 times greater (95% CI: 2.48 to 6.17) when
compared to those who did not default treatment. More-
over, the probability of death was higher in those who
defaulted from treatment early (Fig. 2).
In the univariate analysis, the following variables
were significantly associated with death: age (30–49
years) (Table 3), heavy/dependent alcohol consump-
tion and smoking (Table 4), a CD4 count <200 cells/mm3
(Table 5). In addition to treatment default, a CD4 count
<200 cells/mm3, smoking, extrapulmonary TB and alco-
hol consumption all remained in the final model. (Table 6)
Information on sputum smear was not available for 16.3%
of the TB treatments; for those with available information,
the percentage of TB treatments which had started with a
positive sputum smear was 14.0%. Mortality was higher
among those with a negative sputum smear (HR = 2.1,
95%-CI = 0.9–4.7, p = 0.075) than in those with a positive
result. The probability of death was greater for defaulters
in the the group with positive sputum smear (HR = 2.38,
95%-CI = 0.53–10.79), though it did not reach statistical
significance; in the group with negative (HR = 3.74,
95%-CI = 1.88–7.46) and among those who did not
have the sputum smear performed (HR = 3.30, 95%-
CI = 1.63–6.67). We compared the group of patients
not enrolled because they were not contactable by the
researchers (n = 182) with the group of patients in-
cluded in the study (n = 317) in relation to sex, age
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and default rate. The two groups were similar in rela-
tion to age and sex but the default rate was higher
among those enrolled in the study.
Discussion
The probability of death amongst people living with
HIV who defaulted treatment for TB was almost four
times greater than in those who did not. In addition,
there was an independent association of death and
CD4 count <200 cells/mm3, extrapulmonary TB and
smoking. Light alcohol consumption was found to be
a protective factor for death.
Table 1 Characteristics of the study population
Characteristics Statistics
Number of patients 317
Number of patients who defaulted treatment 91
Number of patients more than one treatmenta 59
Length of follow-up in years
(median and range)
3.54 (41 days; 6.5 years)





< 30 years 66 (20.8%)
30 to 49 years 216 (68.1%)
≥ 50 years 35 (11.1%)
Use of ART 257 (81.1%)
CD4+ <200 cells/mm3 118 (37.2%)
Number of treatmentsb 375
Number of treatment defaults 111
aNumber de patients who had more than one episode of treatment
bNumber of treatments
Fig. 1 Algorithm demonstrating selection of study population
Table 2 Association between death and defaulting from TB
treatment* in a cohort of PLHIV
Time of default







Less than 1 year 4 (11.1%) 4 (20.0%) 6 (31.6%) 14 (18.7%)
From 1 to 2 years 10 (27.8%) 10 (50.0%) 5 (26.3%) 25 (33.3%)
2 years and over 22 (61.1%) 6 (30%) 8 (42.1%) 36 (48.0%)
Total 36 (48.0%) 20 (26.7%) 19 (25.3%) 75 (100%)
* Chi Square Test p-value = 0.096 of the association between death and
defaulting from TB treatment
** first three months after the start of tuberculosis treatment
*** four to six months after the start of tuberculosis treatment
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Log-rank test: p < 0.0001
HR First quarter = 5.31 (3.06 – 9.21)
HR Second quarter = 3.11 (1.78 – 5.45) 
Log-rank test: p < 0.0001
Hazard ratio = 3.91 (2.48 – 6.18) 
Fig. 2 General survival curves and according to the condition of default in a cohort of people living with HIV who initiated the treatment for TB
in Recife, Brazil
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The study of risk factors for the default from TB treat-
ment was well documented in a study by Maruza 2011, but
there are few studies that have focused on the association
between treatment default and death [18, 19, 21]. Moreover,
we were unable to identify in the literature other studies
that have addressed this topic in people living with HIV. In
the present study we observed that the highest frequency of
defaulting treatment occurred during the first quarter,
which corroborates the work of several authors [16, 19, 21].
It is possible that patients present with some clinical im-
provement during this initial phase of treatment, and there-
fore the default rate is higher [16, 22]. However, early





HR (CI 95%) p-value p-valuea
Biologicalb
Sex
Female 23 6.14 (4.08–9.25) 1.0 - -
Male 52 5.44 (4.15–7.15) 0.88 (0.54–1.44) 0.625 0.231
Age group
<30 years 24 8.38 (5.62–12.5) 1.0
30 to 49 years 42 4.61 (3.40–6.23) 0.55 (0.33–0.90) 0.053 0.019
> 50 years 9 6.91 (3.60–13.3) 0.77 (0.35–1.66) 0.506 0.506
BMI
Normal 32 4.35 (3.07–6.15) 1.0
Malnourished 12 4.49 (2.54–7.97) 1.09 (0.56–2.11) 0.797
Overweight/obese 6 3.23 (1.45–7.20) 0.78 (0.32–1.88) 0.591
No information 25 17.8 (12.0–26.3) 3.75 (2.21–6.33) 0.000† 0.725
Anemia
No 17 5.21 (3.24–8.39) 1.0 - -
Yes 47 5.31 (4.00–7.07) 1.03 (0.59–1.79) 0.916 0.271
Socioeconomicb
Origins
Recife 29 5.29 (3.67–7.61) 1.0
Metropolitan Region 36 6.80 (4.90–9.42) 1.29 (0.79–2.10) 0.309
Interior of state 9 4.39 (2.28–8.44) 0.90 (0.42–1.90) 0.781 0.202
Race
White 16 5.79 (3.54–9.44) 1.0
Non-white 58 5.77 (4.45–7.46) 0.99 (0.57–1.72) 0.968 0.100
In a stable relationship
No 38 5.25 (3.82–7.22) 1.0
Yes 36 6.40 (4.61–8.87) 1.20 (0.76–1.90) 0.427 0.427
Schooling
Illiterate 14 6.78 (4.01–11.5) 1.0
From 1 to 9 years 43 6.13 (4.54–8.26) 0.88 (0.48–1.61) 0.677
10 years or more 17 4.56 (2.83–7.33) 0.68 (0.34–1.39) 0.294 0.338
Employed
Yes 11 4.57 (2.53–8.25) 1.0
No 63 6.03 (4.71–7.71) 1.32 (0.69–2.50) 0.400 0.308
Income
> 1 Minimum salary 23 5.01 (3.33–7.54) 1.0
aRisk proportionality test (Schoenfeld residual)
bBiological and socioeconomic conditions when initiating treatment for TB
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HR (CI 95%) p-value p-valuea
Habitsb
Alcohol consumption
No 58 5.97 (4.61–7.72) 1.0
Yes. Light 2 1.09 (0.27–4.28) 0.18 (0.44–0.75) 0.018†
Yes.
Heavy/dependent
13 12.8 (7.41–22.0) 1.97 (1.08–3.61) 0.026† 0.912
Smokerb
No 48 4.74 (3.57–6.29) 1.0
Yes 26 9.47 (6.45–13.9) 1.88 (1.17–3.03) 0.010† 0.304
Use of drugsc
No 53 6.04 (4.61–7.91) 1.0
Yes 21 5.13 (3.34–7.87) 0.83 (0.50–1.37) 0.458 0.586
aProportionality test (Schoenfeld residual)
bCondition of habits when initiating treatment for TB
cUse of drugs (marihuana. cocaine. crack or glue) at some point in life





HR (CI 95%) p-value p-valuea
Related to TBb
Treatment site
Out-patients 31 5.00 (3.51–7.11) 1.0 -
Hospitalized 44 6.51 (4.84–8.75) 1.35 (0.85–2.13) 0.206 0.247
Form of TB
Pulmonary 43 5.32 (3.94–7.17) 1.0 - 0.831
Extrapulmonary 22 6.42 (4.26–9.66) 1.21 (0.73–2.01) 0.456
Pulmonary extrapulmonary
and disseminated
8 5.14 (2.57–10.3) 0.99 (0.47–2.11) 0.987
Previous treatment
No 28 5.16 (3.56–7.47) 1.0 -
Yes 44 7.25 (5.40–9.74) 1.38 (0.86–2.22) 0.178 0.286
Related to HIVb
Opportunistic disease
No 16 7.49 (4.59–12.2) 1.0 - -
Yes 57 5.47 (4.22–7.09) 0.72 (0.42–1.27) 0.264 0.991
Use of ART
Yes 57 5.16 (3.98–6.68) 1.0 - -
No 18 8.48 (5.34–13.5) 1.53 (0.90–2.61) 0.113 0.315
CD4
> 200 cells/mm3 43 3.78 (2.61–5.47) 1.0 - -
< 200 cells/mm3 28 8.94 (6.63–12.1) 2.23 (1.39–3.60) 0.001
No count 4 3.73 (1.40–9.94) 0.80 (0.28–2.30) 0.684 0.238
a Proportionality test (Schoenfeld residual)
bFactors related to TB and HIV when initiating treatment for TB
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default is compatible with a lower chance of curing TB,
with the risk of death being higher in the group of patients
who defaulted treatment earlier (Q1) [21]. In the present
study, deaths occurred at different moments in time (36%
after 2 years), suggesting that the deaths may have occurred
either due to the progression of TB or by the impact of a
more prolonged duration of TB on the progression of HIV
infection. Persistent infections, such as TB, may increase
the patient’s viral load, which leads to a compromised
immune function, lowering survival rates and increasing
the chance of transmitting the HIV virus [10]. A high viral
load may lead to a decrease in the CD4 count, through dif-
ferent mechanisms: accelerating cell loss induced by lysis of
the virus or by destroying both healthy and infected cells,
or even triggering apoptosis (cell death) of both healthy
and infected cells [23]. In the present study it was observed
that patients with a CD4 count of less than 200cells/mm3
presented a more than two-fold probability of death. This
finding is in accordance with that described by other
authors [13, 15, 24, 25] The CD4 cell count is a strong pre-
dictor for the progression of Human Immunodeficiency
Virus - HIV [26] and patient survival. [27] Individuals with
extrapulmonary TB presented a higher probability of death
(borderline significance), which is in agreement with other
studies. [28, 29] This association was explained by
Kingkaew as being due to a delay in diagnosing this form of
TB, for which there is a need to conduct more sophisticated
tests in order to complete the diagnosis, which may delay
initiation of treatment and thus jeopardize patient survival
[29]. In the present study, it was observed that smoking
presented a two-fold increase in the probability of death.
This association has also been described by other authors
[30, 31] and is attributed to a change in the structure and
functioning of the lungs, as well as a decrease in immunity
at both local and systemic levels [31]. Contrary to many
studies, we found that light alcohol consumption was a pro-
tective factor for death, which is contrary to the findings of
other studies that indicate an independent association
between alcohol consumption and death [18, 32]. Perhaps
light alcohol consumption encountered in our study as a
protective factor for death signifies that light alcohol con-
sumption is only a marker for improved conditions of
health, and that this status in itself is a protective factor for
death. The probability of death was higher in patients who
were not using HAART but the difference did not reach
statistical significance (p = 0.351), differing from a previou
paper of our group [33]. It should be emphasized that most
of the patients (81.1%) were using HAART. This study pre-
sented some limitations: the recruitment of patients to the
study was uneven in the two reference services. Approxi-
mately two thirds of the study population was selected from
Hospital Correia Picanço. This was due to logistical issues,
as the fieldwork team was larger in this hospital. However,
we do not believe that it may have nfluenced the associ-
ation between treatment default and death. Another limita-
tion was the exclusion of 192 patients for loss of
recruitment, i.e., patients who started treatment for TB but
were not included in the study. However, the exclusion of
potentially eligible individuals was not due to any specific
criterion and therefore it is unlikely that their absence
distorted our results. In fact, for those patients (recruitment
loss) it was possible to retrieve some information either
from the SINAN or from the dataset of the Cohort AIDS
PE and thus to compare patients enrolled and patients
eligible but not enrolled. The two groups were similar in
relation to age and sex but the default rate was higher
among those enrolled in the study (data not shown). Al-
though the default rate may have been overestimated we
have no reason to think the association between default
from TB treatment and death would differ in the two
groups. As only 14.01% of the TB treatments started with a
positive sputum smear, there may have been some misdiag-
nosis, i.e., some individuals without TB may have been
classified as with TB However, it should be emphasized that
professionals from both reference services have extensive
experience in the diagnosis and treatment of tuberculosis,
patients were followed until the end of tuberculosis treat-
ment and patients for whom there was a change in the
diagnosis of tuberculosis were excluded. The probability of
death was greater for defaulters in the group with a positive,
negative, or not performed sputum smear.
Table 6 Association between death and defaulting from TB
treatment in a cohort of PLHIV, adjusted analysis
Variables HR adjusted (CI 95%) p-value
Default from treatment for TB
No 1.0 -
Yes 3.65 (2.28–5.83) 0.000
Alcohol consumption
No 1.0 -
Yes. Light 0.13 (0.03–0.56) 0.006
Yes. Heavy/dependent 1.22 (0.62–2.43) 0.555
Smoker
No 1.0 -
Yes 2.28 (1.33–3.89) 0.003
Form of TB
Pulmonary 1.0 -





> 200 cells/mm3 1.0 -
< 200 cells/mm3 2.39 (1.44–3.96) 0.001
No count 1.38 (0.45–4.23) 0.572
aCondition when initiating treatment for TB
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Conclusion
The present study demonstrated an association between
treatment default and death, with a higher probability of
death when treatment was defaulted at an early stage. It
is necessary to conduct further studies in order to assess
the manner in which defaulting TB treatment affects the
dynamics of the CD4 count over time, and the resulting
effects of this dynamic on death. It would also be appro-
priate to compare the deaths that occur as a direct
consequence of TB (TB death) with those that occur
due to the impact of TB on the development of
HIV/AIDS.
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